Travere Therapeutics, Inc. · NASDAQ:TVTX
Lyons Gary A sold 8,000 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 14, 2026 · Filed Apr 16, 2026
On Apr 14, 2026, Lyons Gary A (Director) sold 8,000 Travere Therapeutics, Inc. shares at US$41.07 for US$329K under a trading plan, leaving 57,500 shares. Filed Apr 16, 2026 (Form 4).
- Sold
- 8,000 shares
- Price
- US$41.07
- Value
- US$329K
- Holding after
- 57,500 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | Common Stock | Option exercise | 8,000 | US$16.33 | 65,500 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 8,000 | US$41.07 | 57,500 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Lyons Gary A
- Travere Therapeutics, Inc. shareholders
- Form 4 · Lyons Gary A · Aug 19, 2026
- Form 4 · Lyons Gary A · May 21, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026